Lantern Pharma Inc. (LTRN) Stock Price

2.39 ▼ -0.14 (-5.53%)
Open: 2.54 Vol: 61.03K Day's range: 2.34 - 2.595 Mar 13, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
LTRN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.40▲ 2.40▲ 2.42▲ 2.62▼ 2.64▼
MA10 2.41▲ 2.45▼ 2.51▼ 2.68▼ 2.94▼
MA20 2.50▼ 2.55▼ 2.61▼ 2.70▼ 3.20▼
MA50 2.62▼ 2.66▼ 2.70▼ 3.00▼ 3.57▼
MA100 2.68▼ 2.70▼ 2.71▼ 3.29▼ 3.93▼
MA200 2.72▼ 2.76▼ 2.92▼ 3.63▼ 4.47▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.014▼ -0.025▼ -0.008▼ -0.079▼
RSI 39.942▼ 35.413▼ 34.537▼ 33.588▼ 36.264▼
STOCH 26.684     12.870▼ 8.515▼ 29.459     14.523▼
WILL %R -61.905     -74.194     -78.378▼ -93.333▼ -96.988▼
CCI -21.288     -58.959     -88.344     -203.139▼ -116.224▼
Latest Filters Detected On LTRN
▼ MACD $LTRN MACD(12,26,9) Crossed Below Signal Line Set Alert
▼ BREAK $LTRN Price Breaks 60 Days Low Set Alert
▼ BREAK $LTRN Price Breaks 30 Days Low Set Alert
▼ BREAK $LTRN Price Breaks 20 Days Low Set Alert
▼ BREAK $LTRN Price Breaks 10 Days Low Set Alert
Lantern Pharma Inc. News
Is Stride, Inc. (LRN) The Most Promising Education Stock According to Hedge funds?
Thursday, February 26, 2026 07:16 PM
Stride, Inc. (NYSE:LRN) is among the most promising education stocks according to hedge funds. As of February 25, Stride, Inc. (NYSE:LRN) has mixed market sentiment, with 67% of analysts recommending ...
Here’s Why Stride (LRN) Stock Sold Off in Q4
Tuesday, February 24, 2026 12:19 AM
Polen Capital, an investment management company, released its fourth-quarter investor letter for “Polen 5Perspectives Small Growth Strategy”. A copy of the letter can be downloaded here. The Polen ...
Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition
Thursday, February 12, 2026 03:19 AM
Lantern Pharma, Inc. (NASDAQ:LTRN) is one of the best AI penny stocks to buy right now. On January 20, the FDA granted Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-284 an Orphan Drug Designation (ODD).
LTRN historical stock data
date open high low close volume
13/03/26 2.54 2.595 2.34 2.39 61,026
12/03/26 2.68 2.68 2.51 2.53 65,118
11/03/26 2.71 2.75 2.60 2.70 31,802
10/03/26 2.73 2.80 2.70 2.76 22,003
09/03/26 2.68 2.74 2.56 2.74 45,349
06/03/26 2.76 2.76 2.65 2.70 17,492
05/03/26 2.83 2.83 2.64 2.73 23,412
04/03/26 2.75 2.85 2.70 2.82 17,471
03/03/26 2.63 2.77 2.55 2.71 29,650
02/03/26 2.79 2.8278 2.651 2.68 39,143
Quote Details
52wk Low:2.34
52wk High:5.744
Vol:61.03K
Avg Vol(3m):842.6K
1Y Chng:-32.49%
1M Chng:-24.13%
Add to Watch List
More Information
Index US Composite
Market Cap. 28.30M